Skip to main content
SpringerLink
Log in

Besonderheiten bei der Virusausscheidung und Antikörperbildung nach Verabreichung einer „ausgewogenen“ Poliovirus Typ I und II-Lebendimpfstoffmischung

  • Published:
Zeitschrift für Hygiene und Infektionskrankheiten, medizinische Mikrobiologie, Immunologie und Virologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Batson, R., A. Christie andW. J. Cheatham: The infant's serologic response to live poliomyelitis virus vaccine. J. Amer. med. Ass.180, 193–197 (1962).

    Google Scholar 

  2. Campillo-Sainz, C., A. Ornelas Hermandez, J. de Mucha Macias andS. E. Nava: Immunisation of newborn children with living oral trivalent poliovirus vaccine. J. Bact.84, 446–450 (1962).

    PubMed  Google Scholar 

  3. Cox, H. R., V. Cabasso, F. S. Markham, J. M. Moses, A. W. Moyer, M. Roca-Garcia andJ. M. Ruegsegger: Immunological response to trivalent oral poliomyelitis vaccine. Brit. med. J.1959 II, 590–597.

    Google Scholar 

  4. Dardanoni, L., P. Brancato eA. Gullo: Ulteriori indagini sull'attecchimento di virus poliomielitico attenuato (Tipo 1, ceppo LSc di Sabin) in bambini viventi in comunita ad alto livello infezioni enterovirali. Riv. sieroter. Ital.37, 428–443 (1962).

    Google Scholar 

  5. Domok I., and E.Molnar: Virological studies concerning the effectiveness of oral vaccination against poliomyelitis in Hungary (1959–1962). VIII. Symposium, Europ. Assoc. against Poliomyelitis, Prag, 23‥-26. Sept. 1962, p.115–122.

  6. Drozdov, S. G., andG. A. Shirman: Interaction of viruses in the intestinal tract of man. I. Interference between wild and vaccine polio virus strains. Acta virol.5, 210–219 (1961).

    PubMed  Google Scholar 

  7. Ferguson, J. K. W.: Live poliovirus vaccine for oral use. Canad. J. publ. Hlth.53, 135–142 (1962).

    Google Scholar 

  8. Gelfand, H. M.: The occurence in nature of the Coxsackie and ECHO viruses. Progr. med. Virol.3, 193–244 (1961).

    Google Scholar 

  9. —,D. R. LeBlanc, A. H. Holguin andJ. P. Fox: Preliminary report on the susceptibility of newborn infants to infection with poliovirus strains in an attenuated virus vaccine. 2nd Internat. Confer. on live poliovirus vaccines. Washington 1960, Pan Amer. Health Org. Scient. Publ. Nr. 50, p.308–314.

    Google Scholar 

  10. ——,L. Potash, D. I. Clemmer andJ. P. Fox: The spread of living attenuated strains of poliovirus in two communities in southern Louisiana. Amer. J. publ. Hlth50, 767–778 (1960).

    Google Scholar 

  11. —,L. Potash, D. R. LeBlanc andJ. P. Fox: Intrafamilial and interfamilial spread of living vaccine strains of polioviruses. J. Amer. med. Ass.170, 2039–2048 (1959).

    Google Scholar 

  12. Gsell, O., u.E. Wiesmann: Poliomyelitis-Antikörper-Entwicklung bei Erwachsenen nach Schutzimpfung mit Lederle-Triplevaccine von Sabin-Stämmen. Schweiz. med. Wschr.92, 475–480 (1962).

    PubMed  Google Scholar 

  13. Günther, O.: Grundlagen der Poliomyelitis-Schluckimpfung. Dtsch. med. Wschr.87, 432–438 (1962).

    PubMed  Google Scholar 

  14. Haas, R., R. Thomssen, G. Maass, M. Badran, O. Vivell u.H. Sütterle: Virologische Untersuchungen und klinische Beobachtungen nach oraler Poliomyelitis-Schutzimpfung (Sabin Typ 1). Dtsch. med. Wschr.88, 557–564 (1963).

    PubMed  Google Scholar 

  15. Hale, J. H., L. H. Lee andP. S. Gardner: Interference patterns encountered when using attenuated poliovirus vaccine. Brit. med. J.1961II, 728–732.

    Google Scholar 

  16. Henigst, W.: Bildung von neutralisierenden Antikörpern nach Verabreichung eines Kombinationsimpfstoffes mit einem Poliomyelitis-Diphtherie- und Tetanusanteil. Münch. med. Wschr.105, 1205–1209 (1963).

    Google Scholar 

  17. Holguin, A. H., J. S. Reeves andH. M. Gelfand: Immunisation of infants with Sabin oral poliovirus vaccine. Amer. J. publ. Hlth52, 600–610 (1962).

    Google Scholar 

  18. Horstmann, D. M., J. C. Niedermann andJ. R. Paul: Attenuated type I poliovirus vaccine. J. Amer. med. Ass.170, 1–8 (1959).

    Google Scholar 

  19. Koprowski, H., T. W. Norton, G. A. Jervis, T. L. Nelson, D. L. Chadwick, D. J. Nelson andK. F. Meyer: Clinical investigations on attenuated strains of poliomyelitis virus. J. Amer. med. Ass.160, 954–966 (1956).

    Google Scholar 

  20. Krugman, S., J. Warren, M. S. Eiger, P. H. Berman, R. M. Michaels andA. B. Sabin: Immunization with live attenuated poliovirus vaccine. Amer. J. Dis. Child.101, 23–29 (1961).

    PubMed  Google Scholar 

  21. Lepow, M. L., R. J. Warren, N. Gray, V. G. Ingram andF. C. Robbins: Effect of Sabin type I poliomyelitis vaccine administered by mouth to newborn infants. New Engl. J. Med.264, 1071–1078 (1961).

    PubMed  Google Scholar 

  22. Levine, S., andN. Goldblum: Virological findings and antibody response of infants fed multiple type oral poliomyelitis vaccine. 2nd Intern. Conf. on live poliovirus vaccine, Washington 1960. Pan Amer. Health Org. Sci. Publ. No. 50, p. 270–276.

    Google Scholar 

  23. — —, andE. Friedmann: Virologic findings and antibody response of newborns fed multiple type oral poliomyelitis vaccine. Amer. J. Hyg.74, 95–103 (1961).

    PubMed  Google Scholar 

  24. Likar, M., E. O. Bartley andD. C. Wilson: Observations on the interaction of poliovirus in host cells in vitro. III. The effect of some bacterial metabolites and endotoxins. Brit. J. exp. Path.40, 391–397 (1959).

    PubMed  Google Scholar 

  25. Pagano, J. S., S. A. Plotkin andH. Koprowski: Variations in the responses of infants to living attenuated poliovirus vaccine. New Engl. J. Med.264, 155 to 163 (1961).

    Google Scholar 

  26. Plotkin, S. A., J. S.Pagano and H.Koprowski: Vaccination of full-term infants with attenuated polioviruses. 2nd Internat. Conf. Org. Sci. Publ. No.50, p.294–301.

  27. Report of the Public Health Laboratory Service: Trial of living attenuated poliovirus vaccine. Brit. med. J.1961 II, 1037–1044.

  28. Robertson, H. E., M. S. Acker, H. O. Dillenberg, R. Woodrow, R. J. Wilson, W. K. Ing andD. R. E. Macleod: Community-wide use of a “balanced” trivalent oral poliovirus vaccine (Sabin). Canad. J. publ. Hlth53, 179–191 (1962).

    Google Scholar 

  29. Sabin, A. B.: Present status of attenuated live-virus poliomyelitis vaccine. J. Amer. med. Ass.162, 1589–1596 (1956).

    Google Scholar 

  30. —: Properties and behavior of oraly administered attenuated poliovirus vaccine. J. Amer. med. Ass.164, 1216–1223 (1957).

    Google Scholar 

  31. Sabin, A.B., M. Ramos-Alvarez, J. Alvarez-Amezquita, W. Pelon, R. H. Michaels, I. Spigland, M. A. Koch, J. M. Barnes andJ. S. Rhim: Live, orally given poliovirus vaccine. Effects of rapid mass immunisation on population under conditions of massive enteric infection with other viruses. J. Amer. med. Ass.173, 1521–1526 (1960).

    Google Scholar 

  32. Shirman, G. A.: Interaction of viruses in the intestinal tract of man. II. Interference between polio virus vaccine strains. Acta virol.5, 359–366 (1961).

    PubMed  Google Scholar 

  33. Siegert, R., G. Enders-Ruckle, J. Oehme u.H. D. Waller: Der Einfluß der prävakzinalen Immunität auf die Virusausscheidung und Antikörperproduktion nach Polio-Schluckimpfung mit Typ I (Sabin). Dtsch. med. Wschr.88, 1586–1594 (1963).

    PubMed  Google Scholar 

  34. Smorodintsev, A. A., A. I. Drobyshevskaya, N. P. Bulychev, O. M. Chalkina, G. M. Groisman, V. I. Votyakov andG. P. Zhilova: Immunological and epidemiological effectiveness of live poliomyelitis vaccine in the USSR. Bull. Wld. Hlth Org.23, 705–725 (1960).

    Google Scholar 

  35. Voroshilova, M. K., G. P.Taranova, V. I.Zhevandrova, G. A.Koroleva, L. A.Grachewa, M. S.Balayan, N. N.Golubewa, V. P.Emeljanenkova and A. P.Shcheglova: Results of serologic and virologic investigation of children in connection with mass immunization with Sabin oral live poliomyelitis vaccine. VIII. Symposium, Europ. Assoc. against poliomyelitis, Prag, 23.–26. Sept. 1962, p. 165–181.

Download references

Author information

Authors and Affiliations

  1. Staatlichen Bakteriologischen Untersuchungsanstalt München, Deutschland

    Wolf Henigst, Ferdinand Müller & Fritz Würsching

Authors
  1. Wolf Henigst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ferdinand Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fritz Würsching
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Für die sorgfältige und zuverlässige technische Assistenz bei unseren Laboratoriumsarbeiten danken wir insbesondere FrauHelga Krause. Den Schwestern unseres Kinderheimes Ug. sind wir für ihre verständnisvolle und ausdauernde Hilfe bei den Entnahmen der Blutproben und der Sammlung der Stühle zu großem Dank verpflichtet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henigst, W., Müller, F. & Würsching, F. Besonderheiten bei der Virusausscheidung und Antikörperbildung nach Verabreichung einer „ausgewogenen“ Poliovirus Typ I und II-Lebendimpfstoffmischung. Zeitschr. f. Hygiene. 149, 383–400 (1963). https://doi.org/10.1007/BF02153177

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02153177

Search

Navigation